ESTABLISHMENT LABS HOLDINGS
ESTANASDAQTrading Snapshot
- Day Range
- β
- 52-Week Range
- $53.16 β $97.59
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 29.8M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $211M
- Last Q Revenue
- $72M
- P/E Ratio
- -54.1
- P/S Ratio
- 7.8x
- EPS (TTM)
- $-1.26
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.3%
ESTABLISHMENT LABS HOLDINGS
ESTAAbout ESTABLISHMENT LABS HOLDINGS
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates
News unavailable.